Evogene Ltd. (EVGN)
0.5951
-0.09
(-12.87%)
USD |
NASDAQ |
Jun 02, 16:00
0.62
+0.02
(+4.18%)
After-Hours: 20:00
Evogene EPS Diluted (Quarterly) : -0.6028 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0811 |
| Pluri, Inc. | -0.5518 |
| Scinai Immunotherapeutics Ltd. | -0.6037 |
| CollPlant Biotechnologies Ltd. | -0.2253 |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.91M |
| Revenue (Quarterly) | 0.334M |
| Total Expenses (Quarterly) | 6.218M |
| Enterprise Value | 6.592M |
| Gross Profit Margin (Quarterly) | 0.60% |
| Profit Margin (Quarterly) | -1.77K% |
| Earnings Yield | -232.7% |
| Normalized Earnings Yield | -232.70 |